GlassScriptPhysician profile
Bonny Willard
NPI 1891341392
$4,686.96
in general payments reported to CMS, 2019-2025
27 companies · $1,609 in 2025
The $1,609 reported for 2025 was more than what 91% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $898 · 2022: $1,757 · 2023: $368 · 2024: $54.19 · 2025: $1,609.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,191 · Food and Beverage: $841.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,191.16 |
| Food and Beverage | $840.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,933.04 | 2021-2025 | Evenity |
| Spinal Simplicity, LLC | $963.61 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $253.17 | 2021-2023 | Relistor |
| Boston Scientific Corporation | $160.06 | 2022-2023 | |
| Grt US Holding, INC. | $154.09 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $136.80 | 2022 | |
| Lilly USA, LLC | $136.12 | 2021-2022 | |
| Abbvie INC. | $95.95 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $92.76 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $82.73 | 2021 | |
| Pacira Therapeutics, INC. | $81.68 | 2021 | |
| Pfizer INC. | $76.07 | 2023 | |
| Tersera Therapeutics LLC | $72.44 | 2021-2023 | Prialt |
| Lundbeck LLC | $71.69 | 2021-2023 | Vyepti |
| Collegium Pharmaceutical, INC. | $48.38 | 2021-2023 | Belbuca |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $45.58 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $38.35 | 2022-2023 | Ajovy |
| Saluda Medical Americas, INC. | $38.12 | 2024 | Evoke |
| Pacira Pharmaceuticals Incorporated | $32.70 | 2022-2024 | Exparel, Iovera, Zilretta |
| Biodelivery Sciences International, INC. | $29.60 | 2021 | |
| Ibsa Pharma INC. | $26.89 | 2021 | |
| Stimwave Technologies Incorporated | $23.96 | 2021 | |
| Medtronic, INC. | $21.69 | 2023 | Intellis Adaptivestim |
| Vertex Pharmaceuticals Incorporated | $21.24 | 2025 | |
| Vertos Medical, INC. | $21.00 | 2023 | Mild Device Kit |
| Radius Health, INC. | $17.11 | 2025 | Tymlos |
| Nevro Corp. | $12.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bonny Willard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.